Funding Opportunities

• The Interplay of Cell Death Pathways in Cancer Cell Survival and Resistance to Therapy (R01)
  (PA-17-440)
  National Cancer Institute
  Application Receipt Date(s): Standard dates apply , by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
• Typical and Atypical Patterns of Language and Literacy in Dual Language Learners (R01)
  (PA-17-443)
  National Institute on Deafness and Other Communication Disorders
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
• Ethical, Legal, and Social Implications (ELSI) of Genomics Research Project Grant Program (R01)
  (PA-17-444)
  National Human Genome Research Institute
  National Institute on Aging
  National Cancer Institute
  National Institute on Deafness and Other Communication Disorders
  National Institute of Environmental Health Sciences
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Heart, Lung, and Blood Institute
  National Institute of Neurological Disorders and Stroke
  National Institute on Minority Health and Health Disparities
  Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
• Ethical, Legal, and Social Implications (ELSI) of Genomics Small Research Grant Program (R03)
  (PA-17-445)
  National Human Genome Research Institute
  National Institute on Aging
  National Institute of Allergy and Infectious Diseases
  National Cancer Institute
  National Institute on Deafness and Other Communication Disorders
  National Institute of Environmental Health Sciences
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  John E. Fogarty International Center
  Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
• Ethical, Legal, and Social Implications (ELSI) of Genomics Exploratory/Developmental Research Grant Program (R21)
  (PA-17-446)
  National Human Genome Research Institute
  National Institute on Aging
  National Institute of Allergy and Infectious Diseases
  National Cancer Institute
  National Institute on Deafness and Other Communication Disorders
  National Institute of Environmental Health Sciences
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Heart, Lung, and Blood Institute
  National Institute of Neurological Disorders and Stroke
  National Institute on Minority Health and Health Disparities
  Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
• Administrative supplements for validation studies of analytical methods for dietary supplements and natural products (Admin. Suppl.)
  (PA-17-447)
  Office of Dietary Supplements
  National Cancer Institute
  National Institute of Diabetes and Digestive and Kidney Diseases
  National Institute of Environmental Health Sciences
  National Center for Complementary and Integrative Health
  Application Receipt Date(s): October 15, 2017; January 15, 2018; April 15, 2018; by 5:00 PM local time of applicant organization.
• Typical and Atypical Patterns of Language and Literacy in Dual Language Learners (R21)
  (PA-17-448)
  National Institute on Deafness and Other Communication Disorders
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
• The Interplay of Cell Death Pathways in Cancer Cell Survival and Resistance to Therapy (R21)
  (PA-17-449)
  National Cancer Institute
  Application Receipt Date(s): Standard dates apply , by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
• Pregnancy in Women with Disabilities (R03)
  (PA-17-451)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
• Pregnancy in Women with Disabilities (R01)
  (PA-17-452)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
• NIBIB Exploratory/Developmental Research Grant Program (R21)
  (PAR-17-441)
  National Institute of Biomedical Imaging and Bioengineering
  Application Receipt Date(s): Standard dates apply or Month(s) Day(s), Year(s), by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
• Point of Care Technologies Research Network: Point of Care Centers (U54)
  (PAR-17-453)
  National Institute of Biomedical Imaging and Bioengineering
  National Institute on Aging
  National Heart, Lung, and Blood Institute
  John E. Fogarty International Center
  National Center for Complementary and Integrative Health
  Office of Behavioral and Social Sciences Research
  Application Receipt Date(s): October 27, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
• Precompetitive Collaboration on Liquid Biopsy for Early Cancer Assessment (U01)
  (RFA-CA-17-029)
  National Cancer Institute
  Application Receipt Date(s): October 24, 2017 and January 23, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
• Collaborative Research Network for Fusion Oncoproteins in Childhood Cancers (U54)
  (RFA-CA-17-049)
  National Cancer Institute
  Application Receipt Date(s): November 15, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
• Pharmacogenomics of Anti-retroviral Therapy in People Who Inject Drugs (R01)
  (RFA-DA-18-014)
  National Institute on Drug Abuse
  Application Receipt Date(s): December 14, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
• HIV-associated neuropathic pain and opioid interaction (R01)
  (RFA-DA-18-015)
  National Institute on Drug Abuse
  Application Receipt Date(s): December 18, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
• Cardiovascular and Pulmonary Research on E-Cigarettes (R01)
  (RFA-HL-18-024)
  National Heart, Lung, and Blood Institute
  National Cancer Institute
  Application Receipt Date(s): January 16, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
• NINR Exploratory Center (P20)
  (RFA-NR-17-002)
  National Institute of Nursing Research
  Application Receipt Date(s): November 30, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
• NINR Center of Excellence (P30)
  (RFA-NR-17-003)
  National Institute of Nursing Research
  Application Receipt Date(s): November 30, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
• National Metabolomics Data Repository (NMDR) (U2C)
  (RFA-RM-17-011)
  NIH Roadmap Initiatives
  Application Receipt Date(s): October 20, 2017), by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
• Metabolomic Data Analysis and Interpretation Tools (U01)
  (RFA-RM-17-012)
  NIH Roadmap Initiatives
  Application Receipt Date(s): October 20,2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
• Compound Identification Development Cores (U2C)
  (RFA-RM-17-013)
  NIH Roadmap Initiatives
  Application Receipt Date(s): October 20, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
• Stakeholder Engagement and Program Coordination Center (SEPCC) (U2C)
  (RFA-RM-17-014)
  NIH Roadmap Initiatives
  Application Receipt Date(s): October 20, 2017), by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
• Innovative Adaptations to Simplify Existing Technologies for Manipulation and Analysis of Glycans (U01)
  (RFA-RM-17-029)
  NIH Roadmap Initiatives
  Application Receipt Date(s): October 27, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date
• Novel and Innovative Tools to Facilitate Identification, Tracking, Manipulation, and Analysis of Glycans and their Functions (U01)
  (RFA-RM-17-030)
  NIH Roadmap Initiatives
  Application Receipt Date(s): October 27, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due this date